Last CNY3.68 CNY
Change Today +0.06 / 1.66%
Volume 14.4M
000518 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 11:01 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

jiangsu sihuan bioengineer-a (000518) Snapshot

Open
CNY3.62
Previous Close
CNY3.62
Day High
CNY3.78
Day Low
CNY3.60
52 Week High
07/4/14 - CNY3.98
52 Week Low
01/14/14 - CNY3.05
Market Cap
3.8B
Average Volume 10 Days
32.7M
EPS TTM
CNY-0.06
Shares Outstanding
1.0B
EX-Date
04/20/06
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for JIANGSU SIHUAN BIOENGINEER-A (000518)

Related News

No related news articles were found.

jiangsu sihuan bioengineer-a (000518) Related Businessweek News

No Related Businessweek News Found

jiangsu sihuan bioengineer-a (000518) Details

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the manufacture and sale of biological agents, chemical medicines, antineoplastic agents, and health products in China. The company’s products include Carbamazepine tablets for central nervous system; and Ofloxacin tablets primarily used for sensitive caused urinary, reproduction, digestion, respiratory system and skin, soft tissue, and acute bacterial infections. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is based in Wuxi, China.

jiangsu sihuan bioengineer-a (000518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu sihuan bioengineer-a (000518) Key Developments

Jiangsu Sihuan Bioengineering Co., Ltd, Annual General Meeting, May 23, 2014

Jiangsu Sihuan Bioengineering Co., Ltd, Annual General Meeting, May 23, 2014., at 09:30 China Standard Time. Agenda: To approve the 2013 annual report and its summary; to approve the 2013 work report of the board of directors; to approve the 2013 financial resolution report; to approve the 2013 profit distribution plan; to approve the appointment of 2014 financial audit firm and inner control audit firm; to approve the 2013 remuneration for directors, supervisors and senior management; to adjust the allowance for independent directors; and to approve the 2013 work report of the supervisory committee.

Jiangsu Sihuan Bioengineering Co., Ltd to Report Q1, 2014 Results on Apr 30, 2014

Jiangsu Sihuan Bioengineering Co., Ltd announced that they will report Q1, 2014 results on Apr 30, 2014

Jiangsu Sihuan Bioengineering Co., Ltd Approves Amendments to Articles of Association of the Company

Jiangsu Sihuan Bioengineering Co. Ltd. announced at the Extraordinary General Meeting held on March 24, 2014, the shareholders approved amendments to articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000518:CH CNY3.68 CNY +0.06

000518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000518.
View Industry Companies
 

Industry Analysis

000518

Industry Average

Valuation 000518 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.8x
Price/Book 5.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU SIHUAN BIOENGINEER-A, please visit www.jiangsu-sihuan.en.ywsp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.